We found positive enrichment in signaling pathways linked to translation, neuroplasticity, and cytoskeletal regulation, including mTOR, CDC42, TGFβ, neurotrophin signaling, and regulation of actin cytoskeleton, all of which have been shown to be regulated by AD treatment. The gene discussed is CDC42; the disease is Alzheimer disease.